The influenza virus neuraminidase (NA) is primarily involved in the release of progeny
viruses from infected cells—a critical role for virus replication. Compared to the immuno …

Neuraminidase (NA) is an important surface protein on influenza virions, playing an
essential role in the viral life cycle and being a key target of the immune system. Despite the …

Despite the availability of vaccines that efficiently reduce the severity of clinical symptoms,
influenza viruses still cause substantial morbidity and mortality worldwide. In this regard …

Vaccines are instrumental in controlling the burden of influenza virus infection in humans
and animals. Antibodies raised against both major viral surface glycoproteins …

Despite the availability of vaccine prophylaxis and antiviral therapeutics, the influenza virus
continues to have a significant, annual impact on the morbidity and mortality of human …

Neuraminidase (NA) is an influenza surface protein that helps to free viruses from mucin-
associated decoy receptors and to facilitate budding from infected cells. Experiments have …

There is growing appreciation for neuraminidase (NA) as an influenza vaccine target;
however, its antigenicity remains poorly characterized. In this study, we isolated three …

Influenza, the most common infectious disease, poses a great threat to human health
because of its highly contagious nature and fast transmissibility, often leading to high …

Highlights•Neuraminidase (NA)-inhibiting antibodies are an independent correlate of
vaccine efficacy.•Many NA-specific antibodies bind to conserved epitopes and protect …

Neuraminidase (NA) is the second most abundant influenza surface glycoprotein and
contributes to virus replication in several ways, most notably by removing sialic acids from …